Get in touch
555-555-5555
mymail@mailservice.com
Transforming the Sourcing of Biologistics.
We Develop the Future of Biomanufacturing.
Here's what we can do for you:
Building Products
DoveTail Integrated Systems (DoveTail) has developed a proprietary platform technology called the PlantConnex SystemTM and the BioTypeKitTM.
The PlantConnexTM Systems’ technology platform has standardized 80% of the engineering, construction, qualification activities and techniques.
Design
Our industry and operational experience along with our unique approach enables us to be a strong business partner for our clients by adding value throughout their processes. DoveTail staff has extensive experience in the life sciences and have led efforts that resulted in the establishment of numerous, highly complex biomanufacturing facilities.
Consulting
As an integral facet of DoveTail’s approach, DoveTail offers consulting services to clients facilitating the transformation of emerging, established and mature companies by providing consulting services including due diligence support, process modeling and evaluation, troubleshooting, process improvements and process optimization.
DoveTail
What is Dovetail?
DoveTail Integrated Systems has created a unique, sustainable technology platform that standardizes and modularizes complex laboratory and production facilities efficiently and at a lower cost than today’s traditional construction methods. This highly adaptable, cost effective platform solution delivers pre-engineered, pre-fabricated, pre-qualified manufacturing facilities designed to accommodate the use of single use applications and suitable are for a wide range of production processes including therapeutic proteins, vaccine and fill finish configurations.
Today's pharmaceutical and technology facilities are being designed and constructed for maximum flexibility and DoveTail's modular design accommodates this need for flexibility. Our panelized system provides a high degree of flexibility. DoveTail Integrated Systems is poised to leverage major industry trends driving flexible facilities, the rapid adoption of single use technology, increase product titers and technology advances and the trend towards personalized medicine.
Increased Government Regulation and increased pressure by FDA and EMA leads to more complexity in the engineering and construction of biopharmaceutical production facilities. By integrating new technologies in high quality standardized building blocks we dramatically speed up facility delivery lead times. This means clients can focus on their core business during development and construction.
Good Program Management
- Data Under Utilization combine with Data overload
Loss of Time: 9-12 months IND
12-18 months BLA
- Disconnected data between source and CMC
Over 50% of the FDA 483 warning letters site breaches in Data integrity
- Lack of Facility modularity and standardization reduces agility and scalability
Traditional EPCMv slow and costly and has not integrated technology
- Inability to swiftly respond to epidemic and pandemic episodes
COVID-19 in hindsight: The world has proven itself to be "to" slow in response
Lack of Focus
Target Business Case Regulatory and Quality Delays
Organization Silo'd
Marketing, Sales, and CS have different focuses and overlapping expenses
Disconnected & Unstructured Data
Inconsistent collaboration
Lack of data integrity
Talent Without Foundation
Inconsistent talent profiles
Lack of aligned training
